Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Timothy Rodell Insider Profile
4 Followers
Timothy Rodell, CEO & Pres, Director at GlobeImmune, holds 6.09K shares in GlobeImmune (Ticker: GBIM), holds ― shares in Aethlon Medical (Ticker: AEMD). Most recently, Timothy Rodell Bought ― shares of GlobeImmune on Jul 09, 2014 for an estimated value of 50.00K.
Timothy Rodell has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Timothy Rodell holds in companies
Most Profitable Insider Trade
The most profitable trade made by Timothy Rodell
Timothy Rodell's Trading History
GlobeImmune
Jul 09, 2014
CEO & Pres, Director
Informative Buy
50.00K
$304.70
Aethlon Medical
―
CEO, Director
―
―
List of latest transactions for each holding click on a transaction to see Timothy Rodell's performance on stock
You May Also Like
Timothy Rodell insider profile FAQ
What is the percentage of profitable transactions made by Timothy Rodell?
The percentage of profitable transactions made by Timothy Rodell is ―.
What is the average return per transaction made by Timothy Rodell?
The average return per transaction made by Timothy Rodell is ―.
What stocks does Timothy Rodell hold?
Timothy Rodell holds: GBIM, AEMD stocks.
What was Timothy Rodell’s latest transaction?
Timothy Rodell latest transaction was an Informative Buy of $50.00K.
What was Timothy Rodell's most profitable transaction?
Timothy Rodell’s most profitable transaction was an Informative Buy of GBIM stock on July 9, 2014. The return on the trade was -81.40%.
What is Timothy Rodell's role in GlobeImmune?
Timothy Rodell's role in GlobeImmune is CEO & Pres, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.